Sanvita Biotechnologies Private Limited

Sanvita Biotechnologies Private Limited - life sciences in Sangareddy, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2010PTC068348 Incorporated 10 May 2010 ROC Hyderabad HQ Sangareddy, Telangana, India
Active Private Limited Company life sciences
Data last updated
Revenue · FY 2024
₹6.7 Cr
▼ 68% YoY
Net loss · FY 2024
₹39.68 Cr
Latest filing
EBITDA · FY 2024
-₹21.16 Cr
EBITDA margin -316%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹6.52 Cr
Issued & subscribed
Open charges
₹142.19 Cr
Satisfied ₹45 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
101
Provident fund records

About Sanvita Biotechnologies Private Limited

Data last updated:

Sanvita Biotechnologies Private Limited is a private limited company based in Sangareddy, Telangana, India, a subsidiary of Pinipe Projects Private Limited. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 10 May 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2010PTC068348. Its GSTIN is 36AAQCS4165F1Z1 (Telangana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹6.52 Cr. It is led by directors including Krishna Reddy Pinipe (Managing Director) and Modem Reddy Hemanth (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sy No.252/A Mallepally Village Kondapur Mandal, Sangareddy, Telangana, India – 502295.

As per the financials filed for FY 2024, the company reported a revenue of ₹6.7 Cr, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹39.68 Cr and EBITDA of -₹21.16 Cr (EBITDA margin -316%). Revenue has grown at a compounded annual rate (CAGR) of 423% over three years and 123% over five years.

The company has about 101 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹142.19 Cr and satisfied charges of ₹45 Cr on record. Court records list 25 cases involving the company, including 3 filed by the company and 22 filed against it; 13 cases are pending. The company has 13 deals on record (7 funding rounds, 4 secondary share transfers, 2 rights issues), with disclosed funding of ₹76.48 Cr; the latest was in February 2023. Its 3 peer companies in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is SKM Pharma Private Limited, with revenue of ₹7.26 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanvitabiotech.com.

Company details

CIN U24232TG2010PTC068348
Registration Number 068348
Incorporation Date 10 May 2010
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Pinipe Projects Private Limited
Compliance Status Active Compliant

CIN history

Sanvita Biotechnologies has one previous CIN (Corporate Identification Number): U24232AP2010PTC068348. The current CIN is U24232TG2010PTC068348, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2010PTC068348Current
U24232AP2010PTC068348Previous

Contact details

Sanvita Biotechnologies Private Limited's registered office is in Sangareddy, Telangana. Its website is sanvitabiotech.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Sy No.252/A Mallepally Village Kondapur Mandal, Sangareddy, Telangana, India – 502295
  • Industry
    Life Sciences, Biotechnology

To see the full contact details of Sanvita Biotechnologies Private Limited, buy the company report.

Comprehensive company report
Sanvita Biotechnologies Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activities of Sanvita Biotechnologies are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Sanvita Biotechnologies Private Limited, buy the company report.

Financials of Sanvita Biotechnologies Private Limited

FY 2024 filings available

Sanvita Biotechnologies Private Limited reported revenue of ₹6.7 Cr (down 68% YoY) for FY 2024.

Revenue · FY 2024
₹6.7 Cr ▼ 68%
Net loss · FY 2024
₹39.68 Cr
EBITDA · FY 2024
-₹21.16 Cr margin -316%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 68%
3 years · compounded
▲ 423%
5 years · compounded
▲ 123%
EBITDA CAGR growth
1 year
▼ 271%
3 years · compounded
▼ 99%
5 years · compounded
▼ 94%

Revenue fell 68% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 123%. EBITDA fell 271% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹21.16 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹39.68 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-316%
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sanvita Biotechnologies Private Limited, buy the company report.

Board of directors of Sanvita Biotechnologies Private Limited

Sanvita Biotechnologies has 8 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Krishna Reddy PinipeManaging Director12 Feb 20206 Years 8 MonthsCurrent
Modem Reddy HemanthWhole-Time Director11 May 20215 Years 5 MonthsCurrent
Katterapalli Sravan Kumar ReddyWhole-Time Director26 Mar 20224 Years 7 MonthsCurrent
Srikanth PinipeDirector31 Jul 20188 Years 2 MonthsCurrent
Amith Kumar PinipeWhole-Time Director12 Feb 20206 Years 8 MonthsCurrent
Krishnama Chary SribhashyamWhole-Time Director02 Apr 201511 Years 6 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Peer comparison

Sanvita Biotechnologies Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
SKM Pharma Private Limited,₹7.26 Cr (FY 2025)-32.0%Bangalore, Karnataka, India
Prajakt Life Science Private Limited₹7.09 Cr (FY 2024)-14.0%Surat, Gujarat, India
Sanvita Biotechnologies Private Limitedthis company₹6.7 Cr (FY 2024)-₹39.68 Cr-68.0%101Sangareddy, Telangana, India
Siflon Drugs Private Limited₹6.38 Cr (FY 2025)9.0%Hyderabad, Telangana, India

To see the full peer comparison of Sanvita Biotechnologies Private Limited, buy the company report.

Auditor

Sanvita Biotechnologies Private Limited is audited by PCN & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
PCN & AssociatesFY 2023007257S

Shareholding

The shareholding of Sanvita Biotechnologies Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sanvita Biotechnologies Private Limited, buy the company report.

Charges & borrowings

Open charges
₹142.19 Cr
Satisfied charges
₹45 Cr
Breakdown by lending institutions
Canara Bank₹63.89 Cr
Syndicate Bank₹48.18 Cr
Others₹30.12 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Sep 2021100524385Canara Bank₹63.89 CrOpen
09 Dec 2016100068084Others₹15.12 CrOpen
19 Dec 201510615498Others₹15 CrOpen
08 Sep 201410525618Syndicate Bank₹48.18 CrOpen
08 Jul 201310440100State Bank of India₹45 CrSatisfied

To see the full charge records of Sanvita Biotechnologies Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Sanvita Biotechnologies Private Limited has 13 deals on record (7 funding rounds, 4 secondary share transfers, 2 rights issues), with disclosed funding of ₹76.48 Cr; the latest was in February 2023.

Total deals
13
Funding rounds
7
Secondary share transfers
4
Rights issues
2
Disclosed funding
₹76.48 Cr

Deals on record (5 of 13)

WhenDealAmountParties
Jul 2021Secondary share transferUndisclosedBuyer: 4 individuals
Seller: Pinipe Projects Private Limited
Feb 2021Funding round₹12 CrInvestors: Rr Edifice Private Limited, Pinipe Projects Private Limited
Feb 2020Secondary share transferUndisclosedBuyer: Pinipe Projects Private Limited
Seller: 2 individuals
Dec 2018Funding round₹1.75 CrInvestors: Pinipe Projects Private Limited
Dec 2018Funding round₹7.26 CrInvestors: Pinipe Projects Private Limited

To see the full deal history of Sanvita Biotechnologies Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Sanvita Biotechnologies Private Limited was last rated by Crisil on 24 Nov 2020.

Rating agencyRated onRating
Crisil24 Nov 2020

To see the full credit ratings and regulatory alerts of Sanvita Biotechnologies Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sanvita Biotechnologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Sanvita Biotechnologies Private Limited has a workforce of 101 employees on its EPFO records as of Mar 23, 2024, across 1 active EPFO establishment.

Employee count
101
Active EPFO establishments
1
Employee growth
27.85%

GST

Sanvita Biotechnologies has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAQCS4165F1Z1TelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Sanvita Biotechnologies Private Limited, buy the company report.

Recent activity

Sanvita Biotechnologies Private Limited has 23 board changes on record since 2015: 9 appointments and 14 cessations. The latest: Katterapalli Sravan Kumar Reddy ceased to be Additional Director on 01 Jun 2022.

AGM
Sanvita Biotechnologies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Sanvita Biotechnologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Katterapalli Sravan Kumar Reddy ceased to be Additional Director.
Ceased
Kesireddy Saipradyumna Reddy ceased to be Additional Director.
Appointed
Kesireddy Saipradyumna Reddy was appointed as Whole-Time Director.
Appointed
Katterapalli Sravan Kumar Reddy was appointed as Whole-Time Director.
Charges
A charge with Others of Rs. 15.12 Cr registered on 09 Dec 2016 with Charge ID 100068084 was modified on 20 Jan 2022.
Charges
A charge with Canara Bank amounted to Rs. 63.89 Cr with Charge ID 100524385 was registered on 30 Sep 2021.
Ceased
Modem Reddy Hemanth ceased to be Additional Director.
Ceased
Pinipe Baby ceased to be Additional Director.
Appointed
Modem Reddy Hemanth was appointed as Whole-Time Director.
Ceased
Amith Kumar Pinipe ceased to be Director.

22 earlier events are in the company report.

Frequently asked questions

Sanvita Biotechnologies is an active private limited company based in Sangareddy, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 10 May 2010 (16+ years old) and is registered under CIN U24232TG2010PTC068348.

Sanvita Biotechnologies has 8 current directors:

The latest financial statements of Sanvita Biotechnologies on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Sanvita Biotechnologies is 36AAQCS4165F1Z1, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Sanvita Biotechnologies is U24232TG2010PTC068348. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sanvita Biotechnologies has 25 court cases on record: 3 filed by the company and 22 filed against it. 13 are pending. Most are in the district courts.

Sanvita Biotechnologies was incorporated on 10 May 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.

Sanvita Biotechnologies has 13 deals on record (7 funding rounds, 4 secondary share transfers, 2 rights issues), with disclosed funding of ₹76.48 Cr; the latest was in February 2023.

The peers of Sanvita Biotechnologies by revenue are SKM Pharma Private Limited,, Prajakt Life Science Private Limited, Siflon Drugs Private Limited, all in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Katterapalli Sravan Kumar Reddy ceased to be Additional Director on 01 Jun 2022. Kesireddy Saipradyumna Reddy ceased to be Additional Director on 01 Jun 2022. Kesireddy Saipradyumna Reddy was appointed as Whole-Time Director on 21 Apr 2022. Sanvita Biotechnologies has 23 board changes on record in total.

Sanvita Biotechnologies can be reached through the website sanvitabiotech.com. Its registered office is in Sangareddy, Telangana, India.